In 2024, the FDA is looking at copyright for therapeutic use in conjunction with psychological intervention in individuals with PTSD, since the company has approved an application from Lykos Therapeutics.“There’s a huge level of tension creating now to, with the quite the very least, have the scheduling altered to ensure that researchers can re… Read More